DK0651648T3 - Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom - Google Patents
Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdomInfo
- Publication number
- DK0651648T3 DK0651648T3 DK93915854T DK93915854T DK0651648T3 DK 0651648 T3 DK0651648 T3 DK 0651648T3 DK 93915854 T DK93915854 T DK 93915854T DK 93915854 T DK93915854 T DK 93915854T DK 0651648 T3 DK0651648 T3 DK 0651648T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- consumptive
- pct
- thrombo
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929214489A GB9214489D0 (en) | 1992-07-08 | 1992-07-08 | Pharmaceutical compositions and uses therefor |
GB939301251A GB9301251D0 (en) | 1993-01-22 | 1993-01-22 | Pharmaceutical compositions and use therefor |
PCT/EP1993/001790 WO1994001123A1 (en) | 1992-07-08 | 1993-07-08 | Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0651648T3 true DK0651648T3 (da) | 2003-01-06 |
Family
ID=26301225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93915854T DK0651648T3 (da) | 1992-07-08 | 1993-07-08 | Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom |
Country Status (13)
Country | Link |
---|---|
US (1) | US5925344A (da) |
EP (1) | EP0651648B1 (da) |
JP (1) | JP3845112B2 (da) |
AT (1) | ATE228848T1 (da) |
AU (1) | AU674864B2 (da) |
CA (1) | CA2139353C (da) |
DE (1) | DE69332541T2 (da) |
DK (1) | DK0651648T3 (da) |
ES (1) | ES2183814T3 (da) |
IL (1) | IL106272A (da) |
MX (1) | MX9304075A (da) |
PT (1) | PT651648E (da) |
WO (1) | WO1994001123A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7108982B1 (en) | 1999-02-19 | 2006-09-19 | University Of Iowa Research Foundation | Diagnostics and the therapeutics for macular degeneration |
AU3704500A (en) * | 1999-02-19 | 2001-01-22 | University Of Iowa Research Foundation, The | Diagnostics and therapeutics for arterial wall disruptive disorders |
EP1066834A3 (de) * | 1999-07-08 | 2004-06-02 | Thomas Dr. Stief | Pharmazeutische Zusammensetzungen enthaltend ein phagozytenmodulierendes Agens |
WO2002015882A1 (en) * | 2000-08-24 | 2002-02-28 | Lytone Enterprise, Inc. | Delayed release compositions and combinations |
FI20041425A0 (fi) * | 2004-11-05 | 2004-11-05 | Orion Corp | Transmukosaalinen veterinäärinen koostumus |
CN102781471B (zh) * | 2009-10-16 | 2016-10-12 | 奥默罗斯公司 | 通过抑制masp-2依赖性补体活化治疗弥散性血管内凝血的方法 |
US9644035B2 (en) | 2011-04-08 | 2017-05-09 | Omeros Corporation | Methods for treating conditions associated with MASP-2 dependent complement activation |
RU2477530C2 (ru) * | 2011-04-28 | 2013-03-10 | Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" | Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к интерлейкину-6 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5271931A (en) * | 1988-09-14 | 1993-12-21 | The Scripps Research Institute | Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6 |
JPH0372429A (ja) * | 1988-10-07 | 1991-03-27 | Chugai Pharmaceut Co Ltd | 血小板減少症の治療剤 |
JP2805224B2 (ja) * | 1989-01-13 | 1998-09-30 | 味の素株式会社 | 血小板減少症治療剤 |
US5087448A (en) * | 1989-02-02 | 1992-02-11 | The Board Of Regents Of The University Of Oklahoma | Enhancing growth of megakaryocytes in mammals using interleuking 6 |
JPH04218000A (ja) * | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
US5188828A (en) * | 1990-11-08 | 1993-02-23 | Brigham And Women's Hospital | Interleukin-6 to stimulate erythropoietin production |
AU9059991A (en) * | 1990-11-13 | 1992-06-11 | Children's Medical Center Corporation | Controlling beta-amyloid related neuronal degeneration by antagonizing NGF-effected neuronal activity |
EP0560998A4 (en) * | 1991-10-09 | 1993-12-01 | Toray Industries, Inc. | Medicine for preventing and treating bleeding tendency |
-
1993
- 1993-07-07 MX MX9304075A patent/MX9304075A/es not_active IP Right Cessation
- 1993-07-08 DE DE69332541T patent/DE69332541T2/de not_active Expired - Fee Related
- 1993-07-08 WO PCT/EP1993/001790 patent/WO1994001123A1/en active IP Right Grant
- 1993-07-08 IL IL10627293A patent/IL106272A/en not_active IP Right Cessation
- 1993-07-08 CA CA002139353A patent/CA2139353C/en not_active Expired - Fee Related
- 1993-07-08 PT PT93915854T patent/PT651648E/pt unknown
- 1993-07-08 DK DK93915854T patent/DK0651648T3/da active
- 1993-07-08 ES ES93915854T patent/ES2183814T3/es not_active Expired - Lifetime
- 1993-07-08 JP JP50297094A patent/JP3845112B2/ja not_active Expired - Fee Related
- 1993-07-08 AU AU45664/93A patent/AU674864B2/en not_active Ceased
- 1993-07-08 US US08/367,124 patent/US5925344A/en not_active Expired - Fee Related
- 1993-07-08 AT AT93915854T patent/ATE228848T1/de not_active IP Right Cessation
- 1993-07-08 EP EP93915854A patent/EP0651648B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
MX9304075A (es) | 1994-04-29 |
CA2139353C (en) | 2006-11-07 |
IL106272A0 (en) | 1993-11-15 |
AU674864B2 (en) | 1997-01-16 |
US5925344A (en) | 1999-07-20 |
ES2183814T3 (es) | 2003-04-01 |
JP3845112B2 (ja) | 2006-11-15 |
EP0651648A1 (en) | 1995-05-10 |
PT651648E (pt) | 2003-04-30 |
DE69332541D1 (de) | 2003-01-16 |
ATE228848T1 (de) | 2002-12-15 |
DE69332541T2 (de) | 2003-04-17 |
IL106272A (en) | 1999-01-26 |
AU4566493A (en) | 1994-01-31 |
JPH08502028A (ja) | 1996-03-05 |
CA2139353A1 (en) | 1994-01-20 |
EP0651648B1 (en) | 2002-12-04 |
WO1994001123A1 (en) | 1994-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
SE9604793L (sv) | Nya Kristallmodifikationer | |
ATE185548T1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
ITRM920155A0 (it) | Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, e relativo procedimento di preparazione e trattamento con essa di mammiferi. | |
DK0589893T3 (da) | Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori | |
DE69230112D1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
DE59308415D1 (de) | Stabile lyophilisierte pharmazeutische zubereitungen von g-csf | |
DE69400435D1 (de) | Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen | |
ES2134801T3 (es) | Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso. | |
DK0651648T3 (da) | Farmaceutisk præparat indeholdende IL-6. Anvendelse deraf til behandling af konsumptiv trombo-hæmoragisk sygdom | |
DE69232516T2 (de) | Behandlung von neurologischen Zuständen durch eine Interleukin-i-inhibierende Verbindung | |
DE3480764D1 (de) | Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen. | |
NO944214D0 (no) | Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister | |
ES2108122T3 (es) | Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas. | |
CZ157795A3 (en) | Pharmaceutical preparations for treating prostatitis | |
ES2113549T3 (es) | Metodo para inhibir la replicacion de vih empleando il-4. | |
DK0720483T3 (da) | Anvendelse af væksthormon ved fremstilling af et medikament til behandling af iskæmisk hjerneödelæggelse og demens | |
ATE324906T1 (de) | Verwendung von chimäres il6-il6r in huntingtonskrankheit | |
DK0648117T3 (da) | Lægemiddel til at forebygge udvikling af tolerance ved behandling med benzodiazepin-receptor-bindende aktive forbindelser | |
DK0495226T3 (da) | Anvendelse af 3-aryl-5-alkylthio-4H-1,2,4-triazoler til behandling af hyperrefleksi som følge af spinaltrauma | |
DE69927599D1 (de) | Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie | |
SE9301831D0 (sv) | Pharmaceutical compositions | |
PE20011042A1 (es) | Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan | |
FI952855A (fi) | Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö |